financetom
Business
financetom
/
Business
/
Sony India secures $170 mln Asian cricket media rights; Reliance-Disney skips bidding
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sony India secures $170 mln Asian cricket media rights; Reliance-Disney skips bidding
Nov 22, 2024 6:56 AM

By Aditya Kalra and Aleef Jahan C S

Nov 22 (Reuters) -

Sony's ( SONY ) India unit

said

on Friday it had secured the media rights for all Asian

Cricket Council (ACC) tournaments until 2031, which a source

with direct knowledge of the matter put the value at $170

million.

Disney ( DIS ) and Reliance, seen as frontrunners,

did not bid for the rights, another source said on condition of

anonymity.

The deal comes at a crucial time for the country's media

industry, which is going through a consolidation phase after the

$8.5 billion merger of Reliance and Walt Disney's ( DIS ) India media

assets.

Earlier this year, India's antitrust body raised some

concerns about the merged entity's grip over the broadcast of

the world's most populous country's favourite sport, Reuters had

reported.

The entity currently holds the rights to the matches of the

Indian Premier League and International Cricket Council.

The media rights of the ACC were with Disney ( DIS )-owned Star

India until 2023, before they were temporarily extended,

according to media reports.

The newest deal ensures the coverage of Asian cricket's

marquee tournaments across television, digital and audio

platforms, Sony India said in a statement.

The deal will be a significant boost for Sony ( SONY ) to bolster its

foothold in India after it pulled out of a $10 billion merger

with Zee Entertainment earlier this year.

Disney ( DIS ), Reliance and Sony India did not immediately respond

to Reuters' requests for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved